{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20241122",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "80357",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2024/761170s007lbl.pdf",
              "date": "20241125",
              "type": "Label"
            },
            {
              "id": "80429",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2024/761170Orig1s007ltr.pdf",
              "date": "20241126",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20200629",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 4",
          "submission_class_code_description": "Type 4 - New Combination",
          "application_docs": [
            {
              "id": "63759",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/761170Orig1s000ltr.pdf",
              "date": "20200630",
              "type": "Letter"
            },
            {
              "id": "63827",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/761170s000lbl.pdf",
              "date": "20200708",
              "type": "Label"
            },
            {
              "id": "65579",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/761170Orig1s000TOC.html",
              "date": "20201211",
              "type": "Review"
            }
          ]
        }
      ],
      "application_number": "BLA761170",
      "sponsor_name": "GENENTECH INC",
      "openfda": {
        "application_number": [
          "BLA761170"
        ],
        "brand_name": [
          "PHESGO"
        ],
        "generic_name": [
          "PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF"
        ],
        "manufacturer_name": [
          "Genentech, Inc."
        ],
        "product_ndc": [
          "50242-245",
          "50242-260"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "SUBCUTANEOUS"
        ],
        "substance_name": [
          "HYALURONIDASE (HUMAN RECOMBINANT)",
          "PERTUZUMAB",
          "TRASTUZUMAB"
        ],
        "rxcui": [
          "2382604",
          "2382609",
          "2383305",
          "2383307"
        ],
        "spl_id": [
          "c871709f-bb8a-4e51-91ad-31c75d43548e"
        ],
        "spl_set_id": [
          "27dd5e6b-72cd-458d-a015-cf4dab5800da"
        ],
        "package_ndc": [
          "50242-245-01",
          "50242-245-86",
          "50242-260-01",
          "50242-260-86"
        ],
        "nui": [
          "N0000175661",
          "N0000020008",
          "N0000175531",
          "M0009499"
        ],
        "pharm_class_epc": [
          "HER2/neu Receptor Antagonist [EPC]",
          "Endoglycosidase [EPC]"
        ],
        "pharm_class_moa": [
          "HER2/Neu/cerbB2 Antagonists [MoA]"
        ],
        "pharm_class_cs": [
          "Glycoside Hydrolases [CS]"
        ],
        "unii": [
          "K16AIQ8CTM",
          "743QUY4VD8",
          "P188ANX8CK"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "PHESGO",
          "active_ingredients": [
            {
              "name": "PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF",
              "strength": "1,200MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "002",
          "reference_drug": "No",
          "brand_name": "PHESGO",
          "active_ingredients": [
            {
              "name": "PERTUZUMAB, TRASTUZUMAB, AND HYALURONIDASE-ZZXF",
              "strength": "600MG"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "SUBCUTANEOUS",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}